Farber JM - Search Results

1

CCR6 as a possible therapeutic target in psoriasis.

Hedrick MN, Lonsdorf AS, Hwang ST, Farber JM. Hedrick MN, et al. Among authors: farber jm. Expert Opin Ther Targets. 2010 Sep;14(9):911-22. doi: 10.1517/14728222.2010.504716. Expert Opin Ther Targets. 2010. PMID: 20629596 Free PMC article. Review.

2

STRL22 is a receptor for the CC chemokine MIP-3alpha.

Liao F, Alderson R, Su J, Ullrich SJ, Kreider BL, Farber JM. Liao F, et al. Among authors: farber jm. Biochem Biophys Res Commun. 1997 Jul 9;236(1):212-7. doi: 10.1006/bbrc.1997.6936. Biochem Biophys Res Commun. 1997. PMID: 9223454

3

Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding.

Liao F, Shirakawa AK, Foley JF, Rabin RL, Farber JM. Liao F, et al. Among authors: farber jm. J Immunol. 2002 May 15;168(10):4871-80. doi: 10.4049/jimmunol.168.10.4871. J Immunol. 2002. PMID: 11994436

4

Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM. Singh SP, et al. Among authors: farber jm. J Immunol. 2008 Jan 1;180(1):214-21. doi: 10.4049/jimmunol.180.1.214. J Immunol. 2008. PMID: 18097022

5

CCR6 is required for IL-23-induced psoriasis-like inflammation in mice.

Hedrick MN, Lonsdorf AS, Shirakawa AK, Richard Lee CC, Liao F, Singh SP, Zhang HH, Grinberg A, Love PE, Hwang ST, Farber JM. Hedrick MN, et al. Among authors: farber jm. J Clin Invest. 2009 Aug;119(8):2317-29. doi: 10.1172/jci37378. J Clin Invest. 2009. PMID: 19662682 Free PMC article.

6

CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype.

Kitamura K, Farber JM, Kelsall BL. Kitamura K, et al. Among authors: farber jm. J Immunol. 2010 Sep 15;185(6):3295-304. doi: 10.4049/jimmunol.1001156. Epub 2010 Aug 18. J Immunol. 2010. PMID: 20720211 Free PMC article.

7

Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-β2.

Shirakawa AK, Liao F, Zhang HH, Hedrick MN, Singh SP, Wu D, Farber JM. Shirakawa AK, et al. Among authors: farber jm. Cell Mol Immunol. 2010 Nov;7(6):428-39. doi: 10.1038/cmi.2010.46. Epub 2010 Sep 27. Cell Mol Immunol. 2010. PMID: 20871625 Free PMC article.

8

Changes in histone acetylation and methylation that are important for persistent but not transient expression of CCR4 in human CD4+ T cells.

Singh SP, de Camargo MM, Zhang HH, Foley JF, Hedrick MN, Farber JM. Singh SP, et al. Among authors: farber jm. Eur J Immunol. 2010 Nov;40(11):3183-3197. doi: 10.1002/eji.201040443. Epub 2010 Oct 20. Eur J Immunol. 2010. PMID: 20963786 Free PMC article.

9

Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.

Wan W, Lim JK, Lionakis MS, Rivollier A, McDermott DH, Kelsall BL, Farber JM, Murphy PM. Wan W, et al. Among authors: farber jm. Circ Res. 2011 Aug 5;109(4):374-81. doi: 10.1161/CIRCRESAHA.111.242578. Epub 2011 Jun 16. Circ Res. 2011. PMID: 21680896 Free PMC article.

10

CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis.

Mabuchi T, Singh TP, Takekoshi T, Jia GF, Wu X, Kao MC, Weiss I, Farber JM, Hwang ST. Mabuchi T, et al. Among authors: farber jm. J Invest Dermatol. 2013 Jan;133(1):164-71. doi: 10.1038/jid.2012.260. Epub 2012 Aug 16. J Invest Dermatol. 2013. PMID: 22895364 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page